Akorn Pharmaceuticals

Akorn Investor Relations

SEC Filings

Filing date Form Description Filing Group View
SC 13G

A statement of beneficial ownership of common stock by certain persons

3,4,5
SC 13D/A

An amendment to a SC 13D filing

3,4,5
8-K

Report of unscheduled material events or corporate event

Current Reports
8-K

Report of unscheduled material events or corporate event

Current Reports
SC 13G/A

An amendment to the SC 13G filing

3,4,5
SC 13G/A

An amendment to the SC 13G filing

3,4,5
SC 13G/A

An amendment to the SC 13G filing

3,4,5
NT 10-K

Notification that form 10-K will be submitted late

Annual Filings
10-K

Annual report which provides a comprehensive overview of the company for the past year

Annual Filings
10-K/A

Amendment to a previously filed 10-K

Annual Filings